Chemical Structure Of Zileuton (3c61db22 C5f4 45c8 9ace 386dd4267c12 01)
Zileuton Tablet, Multilayer, Extended Release
Product Images NDC 51407-741
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 51407-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Mean Change From Baseline In Trough Fev1 In 12-week Clinical Trial In Patients With Asthma. (3c61db22 C5f4 45c8 9ace 386dd4267c12 02)
51407-741-12.jpg (51407 741 12)
Each tablet contains 600 mg zileuton and comes in a film-coated extended-release form. The tablets should not be chewed, cut or crushed and must be dispensed in a USP tight, light-resistant container. They should be protected from light and kept out of reach of children. The tablets are dispensed in a bottle containing 120 tablets and should be stored within 20° - 25°C (68° - 77°F) and in a controlled room temperature. The patient should be provided with the prescription label as per pharmacist's instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
